Peer Reviewers 2007

Judith Absalon(GlaxoSmithKline (United States)), Charles DiMaggio(New York University), Barry Brown(University of Glasgow), Ricky N. Bluthenthal(Charles R. Drew University of Medicine and Science), Siddharth Agarwal, John J. Chin, Curt G. Beckwith(University of Cape Town), Phil Coffin, Mary T. Bassett(Physicians for Human Rights), J. Ahluwahlia, David D. Celentano(Johns Hopkins University), Allen Cheadle(University of Washington), Carol L. M. Caton, Micaela H. Coady, Sebastian Bonner, Pam Deters, David Cooperman, Angela Bucciarelli, Hannah L. F. Cooper, Kathleen A. Cagney(University of Michigan), Don C. DesJarlais, John Beard, Jennifer Andrea Tenelanda Álvarez, Helen J. Binns(Northwestern University), Sherry Deren, Robert W. Derlet(University of California Davis Medical Center), Jennifer Ahern(Berkeley Public Health Division), Shane Darke(UNSW Sydney), Leo Beletsky(Northeastern University), Janice M. Bell, Adolfo Ariza Ariza, Ginger Chew, Stacey Anderson, Magdalena Cerdá(Hospital Luis Calvo Mackenna), Luisa N. Borrell, Jessica Burke, Semra Aytur, Jackie Campbell, Michael D. Miller(University of Connecticut), Kim N. Dietrich, Déborah Cohen(Jewish General Hospital), Ana V. Diez–Roux(Drexel University), Robert H. Booth, Katherine Kaufer Christoffel(Northwestern University), Eric Brown, Sarah Boslaugh, Deborah Daro(University of Chicago), Jim Anthony, Charles M. Cleland(New York University)

Unknown

January 1, 2008

Cited by 0

Related Papers

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

|New England Journal of Medicine|2020|15.7k

Genome sequencing in microfabricated high-density picolitre reactors

|Nature|2005|7.7k

A Draft Sequence of the Neandertal Genome

|Science|2010|4.6k

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

|New England Journal of Medicine|2020|2.7k

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

|Nature|2020|1.6k